2Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study) : evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis, 2009,68(10):1580-1584.
3Casquero A, Barroso A, Fem6ndez Guerrero ML, G6rgolas M. Use of rituximab as a salvage therapy forHIV-associated muhieentric Castleman disease. Ann Hematol, 2006, 85 (3): 185-187.
4Starkey CR, Joste NE, Lee FC. Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide. Am J Hematol, 2006, 81 (4) : 303- 304.
